Literature DB >> 10929079

Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli.

D M Shaw1, B Gaerthé, R J Leer, J G Van Der Stap, C Smittenaar, M Heijne Den Bak-Glashouwer, J E Thole, F J Tielen, P H Pouwels, C E Havenith.   

Abstract

The delivery of antigens to mucosal-associated lymphoid tissues in paediatric and immunocompromised populations by safe, non-invasive vectors, such as commensal lactobacilli, represents a crucial improvement to prevailing vaccination options. In this report, we describe the oral and nasal immunization of mice with vaccines constructed through an original system for heterologous gene expression in Lactobacillus in which the 50 000-molecular weight (MW) fragment C of tetanus toxin (TTFC) is expressed either as an intracellular or a surface-exposed protein. Our data indicate that L. plantarum is more effective in this respect than L. casei and that, under the experimental conditions investigated, delivery of TTFC expressed as an intracellular antigen is more effective than cell-surface expression. Immunization of mice with live recombinant lactobacilli induced significant levels of circulating TTFC-specific immunoglobulin G (IgG) following nasal or oral delivery of vaccine strains. In addition, following nasal delivery, secretory immunoglobulin A (sIgA) was induced in bronchoalveolar lavage fluids, as were antigen-specific antibody-secreting cells and antigen-specific T-cell activation in draining lymph nodes, substantiating their potential for safe mucosal delivery of paediatric vaccines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10929079      PMCID: PMC2327037          DOI: 10.1046/j.1365-2567.2000.00069.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Oral administration of TNP-Lactobacillus conjugates in mice: a model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli.

Authors:  K Gerritse; M Posno; M M Schellekens; W J Boersma; E Claassen
Journal:  Res Microbiol       Date:  1990 Sep-Oct       Impact factor: 3.992

Review 2.  New strategies for using mucosal vaccination to achieve more effective immunization.

Authors:  R I Walker
Journal:  Vaccine       Date:  1994-04       Impact factor: 3.641

3.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.

Authors:  C C Czerkinsky; L A Nilsson; H Nygren; O Ouchterlony; A Tarkowski
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis.

Authors:  C B Maassen; J D Laman; M J den Bak-Glashouwer; F J Tielen; J C van Holten-Neelen; L Hoogteijling; C Antonissen; R J Leer; P H Pouwels; W J Boersma; D M Shaw
Journal:  Vaccine       Date:  1999-04-23       Impact factor: 3.641

5.  Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans.

Authors:  C D Partidos; M W Steward
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

6.  Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains.

Authors:  J R Butterton; S A Boyko; S B Calderwood
Journal:  Vaccine       Date:  1993-10       Impact factor: 3.641

7.  Construction of genetically defined double aro mutants of Salmonella typhi.

Authors:  D M Hone; A M Harris; S Chatfield; G Dougan; M M Levine
Journal:  Vaccine       Date:  1991-11       Impact factor: 3.641

8.  New use of BCG for recombinant vaccines.

Authors:  C K Stover; V F de la Cruz; T R Fuerst; J E Burlein; L A Benson; L T Bennett; G P Bansal; J F Young; M H Lee; G F Hatfull
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

9.  Cell surface display of recombinant proteins on Staphylococcus carnosus.

Authors:  P Samuelson; M Hansson; N Ahlborg; C Andréoni; F Götz; T Bächi; T N Nguyen; H Binz; M Uhlén; S Ståhl
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

10.  Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus.

Authors:  G Perdigón; M E de Macias; S Alvarez; G Oliver; A P de Ruiz Holgado
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

View more
  35 in total

1.  Cell Wall Anchoring of the Campylobacter Antigens to Lactococcus lactis.

Authors:  Patrycja A Kobierecka; Barbara Olech; Monika Książek; Katarzyna Derlatka; Iwona Adamska; Paweł M Majewski; Elżbieta K Jagusztyn-Krynicka; Agnieszka K Wyszyńska
Journal:  Front Microbiol       Date:  2016-02-18       Impact factor: 5.640

2.  Oral delivery of glucagon like peptide-1 by a recombinant Lactococcus lactis.

Authors:  Payal Agarwal; Pulkit Khatri; Blasé Billack; Woon-Kai Low; Jun Shao
Journal:  Pharm Res       Date:  2014-06-14       Impact factor: 4.200

3.  Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice.

Authors:  Jong-Soo Lee; Haryoung Poo; Dong P Han; Seung-Pyo Hong; Kwang Kim; Michael W Cho; Eun Kim; Moon-Hee Sung; Chul-Joong Kim
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.

Authors:  Carole Balmelli; Stéphane Demotz; Hans Acha-Orbea; Pierre De Grandi; Denise Nardelli-Haefliger
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Lactobacillus plantarum prevents and mitigates alcohol-induced disruption of colonic epithelial tight junctions, endotoxemia, and liver damage by an EGF receptor-dependent mechanism.

Authors:  Pradeep K Shukla; Avtar S Meena; Bhargavi Manda; Maria Gomes-Solecki; Paula Dietrich; Ioannis Dragatsis; RadhaKrishna Rao
Journal:  FASEB J       Date:  2018-06-18       Impact factor: 5.191

6.  Surface display of foreign epitopes on the Lactobacillus brevis S-layer.

Authors:  Silja Avall-Jääskeläinen; Kari Kylä-Nikkilä; Minna Kahala; Terhi Miikkulainen-Lahti; Airi Palva
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

7.  Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria.

Authors:  Corinne Grangette; Heide Müller-Alouf; Pascal Hols; Denise Goudercourt; Jean Delcour; Mireille Turneer; Annick Mercenier
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Reduction of tumor necrosis factor alpha-inducing capacity of recombinant Lactobacillus casei via expression of Salmonella OmpC.

Authors:  A Kajikawa; S Igimi
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

9.  Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease.

Authors:  Beatriz del Rio; Raymond J Dattwyler; Miguel Aroso; Vera Neves; Luciana Meirelles; Jos F M L Seegers; Maria Gomes-Solecki
Journal:  Clin Vaccine Immunol       Date:  2008-07-16

10.  Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.

Authors:  Xinyuan Qiao; Guiwei Li; Xiangqing Wang; Xiaojing Li; Min Liu; Yijing Li
Journal:  BMC Microbiol       Date:  2009-12-04       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.